Pharmaceutical Industry Consolidation
The Atorvastatin API Market is witnessing increased consolidation through mergers and acquisitions.
Larger companies are acquiring smaller, niche API producers to expand capacity, broaden product portfolios, and enter new markets.
This consolidation enhances competitiveness but may also reduce pricing flexibility for buyers, leading to potential market concentration risks.
1 View